We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

The Future of Neuroscience Clinical Trials

Elizabeth McNeil, MD, MSc1; Heather Gunas, JD, MPH2; Walter Koroshetz, MD1
[+] Author Affiliations
1National Institute of Neurological Disorders and Stroke, National Institutes of Health
2National Cancer Institute, National Institutes of Health
JAMA Neurol. 2014;71(5):652. doi:10.1001/jamaneurol.2014.165.
Text Size: A A A
Published online


To the Editor We appreciate Love and Fathallah-Shaykh1 bringing the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) to the attention of the JAMA Neurology readership, and we would like to address the questions raised around NeuroNEXT plans for intellectual property, data sharing, industry involvement, indemnification, and funds for study oversight. In NeuroNEXT, applicants who use the U01 and U44 mechanisms will maintain intellectual property protections afforded under the Bayh-Dole Act (35 USC 201 and 37 CFR 401) so that ownership of intellectual property remains with the inventing site’s institution.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





May 1, 2014
Marissa N. Love, MD; Hassan Fathallah-Shaykh, MD, PhD
1Department of Neurology, University of Alabama at Birmingham
JAMA Neurol. 2014;71(5):652-653. doi:10.1001/jamaneurol.2014.170.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...